1Rockey DC,Weisigrr RA.Endothelinantagnism in experimental hepaticfibrosis:Implication for endothelin inthe pathogenesis of wound healing[].The Journal of Clinical Investigation.1996
2l Bendtson F,Schifter S,Henriksen JH.Increased circulating calcitonin grne-related peptide(CGRP) in cirrhosis[].Journal of Hepatology.1991
2Rockey DC, Weisiger RA. Endothelin antagnism in expeimental hepatic fibrosis: Implication for endothelin in the pathogenesis of wound healing[J].J Clin Invest, 1996, 15(9):1381 - 1388.
3Schepis F, Camma C, Niceforo D. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection[J]. Hepatology, 2001,33(3) :333 - 338.
4Nozoe T,Matsumata T,Sugimachi K.Clinical impact of patients with ruptured esophageal varices with death outcome[J]. Hepatogastroenterology,2002,49(43):185-187.
5Pawlak J, Malkowski P, Wroblewski T,et al.Liver failure during the course of treatment of patients with bleeding esophageal varices[J]. Przegl Lek,2000,57(11):669-671.
6Bauer M,Zhang JX,Bauer I,et al. ET-1 induced alterations of hepatic microcirculation:sinusoidal and extrasinusoidal sites of action[J]. Am J Physiol,1994,267(1 pt 1):G143-G149.
7Matsumoto H,Uemasu J,Kitano M,et al.Clinical significane of plasma endothelin-1 in patients with chronic liver disease[J]. Dig Dis Sci,1994,39(12):2665-2670.
8Isales CM,Nathanson MH,Bruck R,et al.Endothlin-1 induces cholstsis which is mediated by an increase in portal pressure[J]. Biochem Biophys Res Commun,1993,191(3):1244-1251.
9Bluhm RE,Frazer MG,Vore M,et al. Endothelins 1 and 3:potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine[J]. Hepatology, 1993,18(4):961-968.
10Schlichting E,Aspelin T,Grotmol T,et al.Endothelin and hemodynamic responses to superior mesenteric artery occlusion shock and hemorrhagic shock in pigs[J]. Shock,1995,3(2):109-115.
